|
FDA Official: Make Minutes From Agency, Sponsor Meetings Public
CDER should be allowed to release minutes from its meetings with sponsors during the drug approval process so that a more accurate account of the interactions is made public and the FDA can defend itself against accusations that it shifted its expectations during reviews, an FDA official says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives